Abbreviations:CI (Confidence intervals), CRRT (Continous renal replacement therapy), ECPELLA (VA-ECMO and Impella), LVAD (Left ventricular assist device), LV (Left ventricular), RR (Risk ratios), VA-ECMO (Veno-arterial extracorporeal membrane oxygenation)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States.J Am Heart Assoc. 2021; 10e021061
American Heart Association. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. Available at: http://www.ahajournals.org/doi/epub/10.1161/JAHA.113.000590. Accessed on May 21, 2021.
- Management of cardiogenic shock.Eur Heart J. 2015; 36: 1223-1230
- Extracorporeal membrane oxygenation use in acute myocardial infarction in the United States, 2000 to 2014.Circ Heart Fail. 2019; 12e005929
SpringerLink. High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass. Available at: https://link.springer.com/article/10.1007/s00540-011-1253-x. Accessed on April 15, 2021 |.
- Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support.J Card Surg. 2011; 26: 666-668
- Temporary circulatory support for cardiogenic shock.Lancet. 2020; 396: 199-212
- Measuring inconsistency in meta-analyses.BMJ. 2003; 327: 557-560
- Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997; 315: 629-634
- Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.Eur J Heart Fail. 2017; 19: 404-412
- EC-VAD: combined use of extracorporeal membrane oxygenation and percutaneous microaxial pump left ventricular assist device.ASAIO J. 2019; 65: 219-226
Singh A. Impact of Left ventricular Decompression with Impella During venoarterial Extracorporeal Membrane Oxygenation Support in acute myocardial infarction complicated by Cardiogenic Shock. SCAI. Available at: https://scai.confex.com/scai/2019/webprogram/Paper2758.html. Accessed on April 17, 2021.
- Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved outcomes in refractory cardiogenic shock.ASAIO J. 2019; 65: 21-28
- Cardiogenic shock spectrum: outcomes utilizing VA ECMO with or without axillary Impella 5.0: Single Center experience.J Heart Lung Transplant. 2020; 39: S424-S425
- Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: Results from an international, multicenter cohort study.Circulation. 2020; 142: 2095-2106
- Prospective comparison of a percutaneous ventricular assist device and venoarterial extracorporeal membrane oxygenation for patients with cardiogenic shock following acute myocardial infarction.J Am Heart Assoc. 2019; 8e012171
- Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.Clin Res Cardiol. 2018; 107: 287-303
- Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support.ASAIO J. 2017; 63: 257-265
- Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology.J Thorac Dis. 2015; 7: E166-E176
- The effect of Impella CP on cardiopulmonary physiology during venoarterial extracorporeal membrane oxygenation support.Artif Organs. 2017; 41: 1109-1112
- Left ventricular unloading and the role of ECpella.Eur Heart J Suppl. 2021; 23: A27-A34
- Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.Artif Organs. 2019; 43: 745-755
Drs. Bhatia, Jain, Birati, and Fox contributed equally to this work.